Emerging Technologies to Improve the Solubility of Poorly Soluble Drugs

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".

Deadline for manuscript submissions: 10 October 2024 | Viewed by 150

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemical Engineering and Analytical Chemistry, Institute of Biomedicine (IBUB), University of Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
Interests: solubility; dissolution; lipophilicity; acidity; permeability; biomimetic chromatography; high-throughput methodology

E-Mail Website
Guest Editor
Department of Chemical Engineering and Analytical Chemistry, University of Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain
Interests: solubility; dissolution; lipophilicity; acidity; permeability; drug-protein/excipients interactions

Special Issue Information

Dear Colleagues,

Advances in drug development technologies have led to complex chemical entities that, in most cases, have poor aqueous solubility and, consequently, poor bioavailability and efficacy. Solubility is, therefore, one of the main challenges that scientists face in the drug discovery process. This is why the development of strategies aimed at enhancing the solubility and dissolution of poor-soluble compounds has increased in recent years. Some of these approaches are focused on the chemical modification of drugs, others on physical changes, and strategies based on the use of excipients and carriers have also been explored.

This Special Issue aims to provide an overview of the recent advances in drug solubility enhancement strategies. Research areas may include (but are not limited to) the following: solid dispersions; micellization; particle size modification; the stabilization of supersaturated solutions; complexation; salt formation; and crystallization strategies. In this Special Issue, original research articles and reviews are welcome.

We look forward to receiving your contributions.

Prof. Dr. Elisabet Fuguet
Prof. Dr. Clara Ràfols
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • solubility
  • solid dispersions
  • particle size
  • complexation
  • micellization
  • salt formation
  • crystallization
  • supersaturation

Published Papers

This special issue is now open for submission.
Back to TopTop